Literature DB >> 18998044

Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro.

Claudia Guzy1, Anja Schirbel, Daniela Paclik, Bertram Wiedenmann, Axel Dignass, Andreas Sturm.   

Abstract

BACKGROUND: Nutritional support is an established element of therapy for various indications. However, its impact on the mucosal barrier function is not well understood. AIM OF THE STUDY: We investigated the influence of EN and PN on intestinal epithelial cells and peripheral blood (PBMC) and lamina propria mononuclear cells (LPMC), all of which are involved in the mucosal defense against bacterial translocation and systemic inflammation.
METHODS: Integrity of epithelial cells was measured as transepithelial electrical resistance (TER) of confluent Caco-2 monolayers in the presence of 1% EN, PN and a parenteral amino acid mixture (AM). To determine wound healing capacities, an established migration model with IEC-6 cells was used. Furthermore, we investigated apoptosis, cell activation, proliferation and cytokine secretion of Caco-2, HT29 and of stimulated PBMC and LPMC cultured with or without 1 and 5% EN, AM or PN.
RESULTS: We demonstrated that EN, AM and PN promoted the integrity of the epithelial monolayer and reconstituted epithelial cell continuity TGF-beta-dependently and -independently. Interestingly, only PN induced apoptosis and decreased the mitochondrial membrane potential. The activation status of PBMC was significantly reduced by EN and AM. Specifically, EN leads to an increased apoptosis rate, inhibited cell cycle progression and increased pro-inflammatory cytokine secretion. Both EN and PN reduced the activation status and the release of pro- and anti-inflammatory cytokines.
CONCLUSIONS: Our study provides evidence that by promoting wound healing and regulating T cell function, EN, AM, and PN potently interact with the intestinal barrier and immune system, thus justifying its use in diseases accompanied by impaired mucosal barrier function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998044     DOI: 10.1007/s00394-008-0754-3

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  35 in total

Review 1.  Intestinal barrier function.

Authors:  Daniel C Baumgart; Axel U Dignass
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-11       Impact factor: 4.294

Review 2.  Regulation of apoptosis during homeostasis and disease in the intestinal epithelium.

Authors:  Karen L Edelblum; Fang Yan; Toshimitsu Yamaoka; D Brent Polk
Journal:  Inflamm Bowel Dis       Date:  2006-05       Impact factor: 5.325

Review 3.  Risks and benefits of nutritional support during critical illness.

Authors:  Yves Debaveye; Greet Van den Berghe
Journal:  Annu Rev Nutr       Date:  2006       Impact factor: 11.848

Review 4.  Restoration of barrier function in injured intestinal mucosa.

Authors:  Anthony T Blikslager; Adam J Moeser; Jody L Gookin; Samuel L Jones; Jack Odle
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

5.  Lack of enteral nutrition--effects on the intestinal immune system.

Authors:  Barbara E Wildhaber; Hua Yang; Ariel U Spencer; Robert A Drongowski; Daniel H Teitelbaum
Journal:  J Surg Res       Date:  2005-01       Impact factor: 2.192

Review 6.  Role of the gut lymphatic system in multiple organ failure.

Authors:  E A Deitch
Journal:  Curr Opin Crit Care       Date:  2001-04       Impact factor: 3.687

7.  Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Authors:  Andreas Sturm; Klaus Rilling; Daniel C Baumgart; Konstantinos Gargas; Tay Abou-Ghazalé; Bärbel Raupach; Jana Eckert; Ralf R Schumann; Corinne Enders; Ulrich Sonnenborn; Bertram Wiedenmann; Axel U Dignass
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling.

Authors:  Andreas Sturm; Jugoh Itoh; James W Jacobberger; Claudio Fiocchi
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 9.  Enteral nutrition versus parenteral nutrition--the risks and benefits.

Authors:  Khursheed N Jeejeebhoy
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2007-05

10.  Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model.

Authors:  R D Berg; A W Garlington
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

View more
  9 in total

1.  Markers of inflammation and coagulation may be modulated by enteral feeding strategy.

Authors:  Julie A Bastarache; Lorraine B Ware; Timothy D Girard; Arthur P Wheeler; Todd W Rice
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-02-07       Impact factor: 4.016

Review 2.  Nutritional status and nutritional therapy in inflammatory bowel diseases.

Authors:  Corina Hartman; Rami Eliakim; Raanan Shamir
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

3.  Diet affects symptoms and medication response in inflammatory bowel disease.

Authors:  Vikas Pabby; Sonia Friedman
Journal:  Dig Dis Sci       Date:  2013-05       Impact factor: 3.199

Review 4.  Enteral versus parenteral nutrition in critically ill patients with severe pancreatitis: a meta-analysis.

Authors:  H Yao; C He; L Deng; G Liao
Journal:  Eur J Clin Nutr       Date:  2017-09-13       Impact factor: 4.016

5.  Permissive underfeeding, cytokine profiles and outcomes in critically ill patients.

Authors:  Yaseen Arabi; Dunia Jawdat; Abderrezak Bouchama; Hani Tamim; Waleed Tamimi; Mohammed Al-Balwi; Hasan M Al-Dorzi; Musharaf Sadat; Lara Afesh; Mashan L Abdullah; Walid Mashaqbeh; Maram Sakhija; Mohamed A Hussein; Adila ElObeid; Abdulaziz Al-Dawood
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

Review 6.  Efficacy of enteral nutrition in patients with Crohn's disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis.

Authors:  Fumihito Hirai; Teruyuki Takeda; Yasumichi Takada; Masahiro Kishi; Tsuyoshi Beppu; Noritaka Takatsu; Masaki Miyaoka; Takashi Hisabe; Kenshi Yao; Tosiharu Ueki
Journal:  J Gastroenterol       Date:  2019-10-22       Impact factor: 7.527

7.  Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults.

Authors:  Fumihito Hirai; Hiroshi Ishihara; Shinichirou Yada; Motohiro Esaki; Tomohisa Ohwan; Ryoichi Nozaki; Shinya Ashizuka; Haruhiko Inatsu; Hidehisa Ohi; Kunihiko Aoyagi; Yohei Mizuta; Takayuki Matsumoto; Toshiyuki Matsui
Journal:  Dig Dis Sci       Date:  2012-08-29       Impact factor: 3.199

8.  Fish oil-derived lipid emulsion induces RIP1-dependent and caspase 8-licensed necroptosis in IEC-6 cells through overproduction of reactive oxygen species.

Authors:  Jun-Kai Yan; Wei-Hui Yan; Wei Cai
Journal:  Lipids Health Dis       Date:  2018-06-23       Impact factor: 3.876

9.  Modulation of the Epithelial-Immune Cell Crosstalk and Related Galectin Secretion by DP3-5 Galacto-Oligosaccharides and β-3'Galactosyllactose.

Authors:  Veronica Ayechu-Muruzabal; Melanie van de Kaa; Reshmi Mukherjee; Johan Garssen; Bernd Stahl; Roland J Pieters; Belinda Van't Land; Aletta D Kraneveld; Linette E M Willemsen
Journal:  Biomolecules       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.